IQVIA Holdings Analytics Inc. IQV has reported impressive first-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate. Adjusted earnings were $2.70 per share, outpacing the Zacks Consensus Estimate by 2.7% and rising 6.3% on a year-over-year basis. Total revenues of $3.8 billion surpassed the consensus estimate by 1.6% and grew 2.5% from the year-ago quarter. The IQV stock has lost 33.5% over the past year compared with the 11.5% decline of the industry it belongs to and against the 9.1% rise of the Zacks S&P 500 Composite. IQVIA’s Quarterly Details The Research and Development segment’s revenues were $2.1 billion, increasing marginally from the year-ago quarter and 1.1% on a constant-currency basis. The metric met our estimate. IQVIA Holdings Inc. Price, Consensus and EPS SurpriseIQVIA Holdings Inc. Price, Consensus and EPS Surprise IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote Revenues from the Technology and Analytics segment were $1.5 billion, growing 6.4% from the year-ago quarter and 7.6% on a constant-currency basis. The metric met our estimate. Contract Sales and Medical Solutions revenues decreased 4.2% on a year-over-year basis to $181 million and increased 2.1% on a constant-currency basis. The metric missed our estimation of $192.4 million. Adjusted EBITDA for the first quarter of 2025 was $883 million, a 2.4% rise from the year-ago quarter and lagging our projection of $886.6 million. The company exited the quarter with cash and cash equivalents of $1.7 billion, flat with the preceding quarter. Long-term debt (less current portion) was $13.1 billion compared with $12.8 billion at the end of the fourth quarter of 2024. Net cash generated from operating activities was $586 million and the capital expenditure for the quarter was $142 million. The company generated a free cash flow of $426 million in the quarter. IQV’s 2025 Guidance For 2025, IQVIA has raised its revenue guidance to $16.00-$16.40 billion from the preceding quarter’s view of $15.72-$16.12 billion. The guided range is higher than the Zacks Consensus Estimate for revenues of $15.86 billion. The company expects an adjusted EPS of $11.70-$12.10. The mid-point ($11.90) of the guided range is higher than the Zacks Consensus Estimate for earnings of $11.84. IQVIA’s adjusted EBITDA view for the same period is $3.76-$3.88 billion. IQV carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Earnings Snapshot of Peers The Interpublic Group of Companies, Inc. IPG reported mixed first-quarter 2025 results. Story Continues IPG’s adjusted earnings of 33 cents per share surpassed the Zacks Consensus Estimate by 10% but decreased 8.3% from the year-ago quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Revenues before billable expenses (net revenues) of $2 billion missed the consensus estimate by a slight margin and declined 8.3% year over year. Waste Connections, Inc. WCN posted impressive first-quarter 2025 results. WCN’s adjusted earnings (excluding 20 cents from non-recurring items) of $1.13 per share surpassed the Zacks Consensus Estimate by 5.6% and increased 8.7% year over year. Revenues of $2.2 billion beat the consensus estimate marginally and grew 7.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Interpublic Group of Companies, Inc. (The) (IPG):Free Stock Analysis Report Waste Connections, Inc. (WCN):Free Stock Analysis Report IQVIA Holdings Inc. (IQV):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...